AMCP Format 4.1 Teaser Image

AMCP Format for Formulary Submissions — Guidance on Submission of Pre-Approval and Post-Approval Clinical and Economic Information and Evidence, Version 4.1

The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.
Formulary & Utilization Management, Format for Formulary Submissions
Food allergies thumbnail

JMCP Findings - Navigating the Landscape of Food Allergies

AMCP brought together experts to learn about food allergies caused by the body reacting strongly to certain foods. Food allergies can be difficult to handle and costly for both people and the health care system. New medicines could help prevent allergic reactions, including anaphylaxis, caused by accidental exposure to foods. It is important for health care leaders to make sure people with food allergies see the right doctors, get the right medicine at the right time, and help prevent allergic reactions and related health care costs.
Market Insights, Food Allergy
Food allergies thumbnail

JMCP Findings - Navigating the Landscape of Food Allergies

AMCP brought together experts to learn about food allergies caused by the body reacting strongly to certain foods. Food allergies can be difficult to handle and costly for both people and the health care system. New medicines could help prevent allergic reactions, including anaphylaxis, caused by accidental exposure to foods. It is important for health care leaders to make sure people with food allergies see the right doctors, get the right medicine at the right time, and help prevent allergic reactions and related health care costs.
Market Insights, Food Allergy
ALS Thumbnail

JMCP Outsert - Exploring Opportunities to Improve the Quality of Life for Those with Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive, and fatal neurodegenerative disease characterized by loss of motor neurons in the brain and spinal cord. The etiology of ALS is unknown, however it is thought to be due to a combination of genetic predisposition, environmental exposures, and agingrelated dysfunction. The clinical presentation of ALS varies depending on which motor neurons are affected. ALS commonly presents with localized weakness that progresses to muscle paralysis, respiratory failure, and death.
Market Insights, Amyotrophic Lateral Sclerosis
AMCP Regulatory NewsBreaks

June 30, 2023: CMS Issues Revised IRA Negotiation Guidance

On June 30, 2023, the Centers for Medicare and Medicaid Services (CMS) issued final guidance on the Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program for the initial price applicability year 2026 (Revised Guidance).